Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Cellular and Molecular Life Sciences : CMLS|January 11, 2026
HOXC6 overexpression stimulates cell migration and correlates with poor prognosis in head and neck squamous cell carcinomaSubhendu Roy Choudhury, Ishita Gupta, Ian Mills, et al.British Journal of Haematology|November 19, 2009
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myelomaWilliam I Bensinger, Sundar Jagannath, Robert Vescio, et al.Blood|March 17, 2012
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myelomaShaji Kumar, Ian Flinn, Paul G Richardson, et al.Plos One|September 1, 2020
The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurementsMaria-Teresa Cedena, Estela Martin-Clavero, Sandy Wong, et al.Head & Neck|January 31, 2012
Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinomaCaroline J Voskens, Duane Sewell, Ronna Hertzano, et al.Blood Advances|May 21, 2020
Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myelomaRafael Alonso, María-Teresa Cedena, Sandy Wong, et al.Blood Advances|April 4, 2024
CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapyGuy Ledergor, Zenghua Fan, Kai Wu, et al.Transplantation and Cellular Therapy|February 22, 2023
Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood DonorsHenry Barreras, Sabrina N Copsel, Cameron S Bader, et al.Journal of Hematology & Oncology|August 18, 2021
Making clinical decisions based on measurable residual disease improves the outcome in multiple myelomaJoaquin Martinez-Lopez, Rafael Alonso, Sandy W Wong, et al.Nature Biotechnology|August 25, 2022
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktailsBrian R Shy, Vivasvan S Vykunta, Alvin Ha, et al.Pageof 7